VThunter
a database for single-cell screening of virus target cells in animal kingdom
Pigeon

Taxonomy: Cellular organisms; Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata; Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Sauropsida; Sauria; Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda; Coelurosauria; Aves; Neognathae; Columbiformes; Columbidae; Columba,

Latin Name: Columba livia domestica

Tested tissues: Lung, PBMC,

Data set information
Project Date Technology Tissue Condition Cell PMID/DOI
Vthunter_0051 2021.04 10X Genomics Lung Normal 5545 Link
Vthunter_100008 2021.05 iDrop PBMC Normal 5072 Link
Virus Virus Name GeneTop 5 cell types expressing viral receptor ordered by expression proportion
Adeno-associated virus - 3
PBMC-Macrophage : 99.25% ;
PBMC-B cells : 96.75% ;
PBMC-T cells : 94.12% ;
PBMC-Eosinophil cells : 90.00% ;
PBMC-Erythroblasts : 82.73% ;
Adeno-associated virus 9
PBMC-Macrophage : 99.25% ;
PBMC-B cells : 96.75% ;
PBMC-T cells : 94.12% ;
PBMC-Eosinophil cells : 90.00% ;
PBMC-Erythroblasts : 82.73% ;
Adeno-associated virus - 8
PBMC-Macrophage : 99.25% ;
PBMC-B cells : 96.75% ;
PBMC-T cells : 94.12% ;
PBMC-Eosinophil cells : 90.00% ;
PBMC-Erythroblasts : 82.73% ;
Dengue virus
PBMC-Macrophage : 99.25% ;
PBMC-B cells : 96.75% ;
PBMC-T cells : 94.12% ;
PBMC-Eosinophil cells : 90.00% ;
PBMC-Erythroblasts : 82.73% ;
PBMC-Macrophage : 17.54% ;
Lung-Ciliated cells : 6.97% ;
Lung-Macrophages : 5.88% ;
Venezuelan equine encephalitis virus
PBMC-Macrophage : 99.25% ;
PBMC-B cells : 96.75% ;
PBMC-T cells : 94.12% ;
PBMC-Eosinophil cells : 90.00% ;
PBMC-Erythroblasts : 82.73% ;
Adeno-associated virus - 2
PBMC-Macrophage : 99.25% ;
PBMC-B cells : 96.75% ;
PBMC-T cells : 94.12% ;
PBMC-Eosinophil cells : 90.00% ;
PBMC-Erythroblasts : 82.73% ;
PBMC-Macrophage : 79.10% ;
PBMC-Eosinophil cells : 60.00% ;
PBMC-Platelets : 48.25% ;
PBMC-T cells : 28.22% ;
PBMC-B cells : 20.78% ;
PBMC-Macrophage : 15.86% ;
PBMC-Eosinophil cells : 10.00% ;
PBMC-B cells : 6.49% ;
Classical swine fever virus
PBMC-Macrophage : 99.25% ;
PBMC-B cells : 96.75% ;
PBMC-T cells : 94.12% ;
PBMC-Eosinophil cells : 90.00% ;
PBMC-Erythroblasts : 82.73% ;
PBMC-Macrophage : 33.21% ;
PBMC-Eosinophil cells : 10.00% ;
PBMC-B cells : 7.14% ;
PBMC-T cells : 6.98% ;
PBMC-Monocytes : 6.05% ;
Sindbis virus
PBMC-Macrophage : 99.25% ;
PBMC-B cells : 96.75% ;
PBMC-T cells : 94.12% ;
PBMC-Eosinophil cells : 90.00% ;
PBMC-Erythroblasts : 82.73% ;
Human parechovirus 1
PBMC-Platelets : 91.84% ;
PBMC-Macrophage : 48.32% ;
PBMC-Eosinophil cells : 40.00% ;
PBMC-Monocytes : 35.95% ;
PBMC-Erythroblasts : 32.03% ;
PBMC-Macrophage : 78.17% ;
PBMC-Eosinophil cells : 70.00% ;
PBMC-Platelets : 67.88% ;
PBMC-Monocytes : 27.94% ;
PBMC-B cells : 20.78% ;
Coxsackievirus A9
PBMC-Platelets : 91.84% ;
PBMC-Macrophage : 48.32% ;
PBMC-Eosinophil cells : 40.00% ;
PBMC-Monocytes : 35.95% ;
PBMC-Erythroblasts : 32.03% ;
PBMC-Macrophage : 78.17% ;
PBMC-Eosinophil cells : 70.00% ;
PBMC-Platelets : 67.88% ;
PBMC-Monocytes : 27.94% ;
PBMC-B cells : 20.78% ;
Lung-ATII : 6.67% ;
Lung-Secretory cells : 5.23% ;
Human betaherpesvirus 5
PBMC-Platelets : 91.84% ;
PBMC-Macrophage : 48.32% ;
PBMC-Eosinophil cells : 40.00% ;
PBMC-Monocytes : 35.95% ;
PBMC-Erythroblasts : 32.03% ;
PBMC-Macrophage : 79.10% ;
PBMC-Eosinophil cells : 60.00% ;
PBMC-Platelets : 48.25% ;
PBMC-T cells : 28.22% ;
PBMC-B cells : 20.78% ;
PBMC-Macrophage : 78.17% ;
PBMC-Eosinophil cells : 70.00% ;
PBMC-Platelets : 67.88% ;
PBMC-Monocytes : 27.94% ;
PBMC-B cells : 20.78% ;
Lung-Smooth muscle cells : 6.10% ;
Hantaan orthohantavirus
PBMC-Platelets : 91.84% ;
PBMC-Macrophage : 48.32% ;
PBMC-Eosinophil cells : 40.00% ;
PBMC-Monocytes : 35.95% ;
PBMC-Erythroblasts : 32.03% ;
Simian rotavirus A strain RRV
PBMC-Platelets : 91.84% ;
PBMC-Macrophage : 48.32% ;
PBMC-Eosinophil cells : 40.00% ;
PBMC-Monocytes : 35.95% ;
PBMC-Erythroblasts : 32.03% ;
PBMC-Macrophage : 79.10% ;
PBMC-Eosinophil cells : 60.00% ;
PBMC-Platelets : 48.25% ;
PBMC-T cells : 28.22% ;
PBMC-B cells : 20.78% ;
PBMC-Macrophage : 78.17% ;
PBMC-Eosinophil cells : 70.00% ;
PBMC-Platelets : 67.88% ;
PBMC-Monocytes : 27.94% ;
PBMC-B cells : 20.78% ;
PBMC-Macrophage : 69.03% ;
Lung-Ciliated cells : 62.96% ;
PBMC-B cells : 53.90% ;
Lung-Secretory cells : 33.72% ;
PBMC-T cells : 29.31% ;
PBMC-Platelets : 62.26% ;
PBMC-Macrophage : 20.90% ;
PBMC-Monocytes : 19.61% ;
PBMC-T cells : 15.25% ;
PBMC-Erythroblasts : 14.29% ;
West Nile virus
PBMC-Platelets : 91.84% ;
PBMC-Macrophage : 48.32% ;
PBMC-Eosinophil cells : 40.00% ;
PBMC-Monocytes : 35.95% ;
PBMC-Erythroblasts : 32.03% ;
PBMC-Macrophage : 78.17% ;
PBMC-Eosinophil cells : 70.00% ;
PBMC-Platelets : 67.88% ;
PBMC-Monocytes : 27.94% ;
PBMC-B cells : 20.78% ;
Foot-and-mouth disease virus
PBMC-Platelets : 91.84% ;
PBMC-Macrophage : 48.32% ;
PBMC-Eosinophil cells : 40.00% ;
PBMC-Monocytes : 35.95% ;
PBMC-Erythroblasts : 32.03% ;
PBMC-Macrophage : 79.10% ;
PBMC-Eosinophil cells : 60.00% ;
PBMC-Platelets : 48.25% ;
PBMC-T cells : 28.22% ;
PBMC-B cells : 20.78% ;
PBMC-Macrophage : 78.17% ;
PBMC-Eosinophil cells : 70.00% ;
PBMC-Platelets : 67.88% ;
PBMC-Monocytes : 27.94% ;
PBMC-B cells : 20.78% ;
Lung-Ciliated cells : 15.69% ;
Lung-Macrophages : 11.76% ;
Lung-Secretory cells : 6.98% ;
Lung-ATII : 6.67% ;
Lung-Secretory cells : 5.23% ;
Human gammaherpesvirus 8
PBMC-Platelets : 91.84% ;
PBMC-Macrophage : 48.32% ;
PBMC-Eosinophil cells : 40.00% ;
PBMC-Monocytes : 35.95% ;
PBMC-Erythroblasts : 32.03% ;
PBMC-Macrophage : 78.17% ;
PBMC-Eosinophil cells : 70.00% ;
PBMC-Platelets : 67.88% ;
PBMC-Monocytes : 27.94% ;
PBMC-B cells : 20.78% ;
Lassa mammarenavirus
PBMC-Macrophage : 91.42% ;
Lung-Ciliated cells : 55.99% ;
Lung-Secretory cells : 46.51% ;
Lung-Smooth muscle cells : 44.52% ;
Lung-T cells : 41.00% ;
PBMC-Macrophage : 17.54% ;
Lung-Ciliated cells : 6.97% ;
Lung-Macrophages : 5.88% ;
Hepacivirus C
PBMC-Macrophage : 88.43% ;
PBMC-B cells : 60.39% ;
Lung-Fibroblasts : 32.15% ;
PBMC-Monocytes : 30.07% ;
PBMC-Eosinophil cells : 30.00% ;
PBMC-Erythroblasts : 66.56% ;
PBMC-Macrophage : 23.13% ;
PBMC-Eosinophil cells : 20.00% ;
Lung-Macrophages : 11.76% ;
PBMC-B cells : 11.69% ;
PBMC-Macrophage : 29.10% ;
Lung-Smooth muscle cells : 6.10% ;
Influenza A virus
PBMC-Macrophage : 83.77% ;
Lung-Ciliated cells : 8.06% ;
PBMC-B cells : 7.79% ;
PBMC-T cells : 5.68% ;
Lung-Fibroblasts : 47.68% ;
Lung-Smooth muscle cells : 45.49% ;
Lung-Ciliated cells : 29.63% ;
Lung-ATII : 23.33% ;
Lung-Endothelial cells : 23.32% ;
PBMC-Macrophage : 34.14% ;
Lung-Ciliated cells : 22.66% ;
Lung-Secretory cells : 11.63% ;
PBMC-B cells : 9.74% ;
Lung-Smooth muscle cells : 9.02% ;
Lung-Smooth muscle cells : 6.10% ;
Equid alphaherpesvirus 1
PBMC-Macrophage : 79.10% ;
PBMC-Eosinophil cells : 60.00% ;
PBMC-Platelets : 48.25% ;
PBMC-T cells : 28.22% ;
PBMC-B cells : 20.78% ;
PBMC-Macrophage : 74.25% ;
PBMC-T cells : 47.76% ;
PBMC-Eosinophil cells : 40.00% ;
PBMC-B cells : 33.12% ;
PBMC-Monocytes : 17.97% ;
Human parvovirus B19
PBMC-Macrophage : 79.10% ;
PBMC-Eosinophil cells : 60.00% ;
PBMC-Platelets : 48.25% ;
PBMC-T cells : 28.22% ;
PBMC-B cells : 20.78% ;
Human gammaherpesvirus 4
PBMC-Macrophage : 79.10% ;
PBMC-Eosinophil cells : 60.00% ;
PBMC-Platelets : 48.25% ;
PBMC-T cells : 28.22% ;
PBMC-B cells : 20.78% ;
PBMC-Macrophage : 27.61% ;
PBMC-B cells : 7.79% ;
Echovirus E1
PBMC-Macrophage : 79.10% ;
PBMC-Eosinophil cells : 60.00% ;
PBMC-Platelets : 48.25% ;
PBMC-T cells : 28.22% ;
PBMC-B cells : 20.78% ;
PBMC-Platelets : 62.26% ;
PBMC-Macrophage : 20.90% ;
PBMC-Monocytes : 19.61% ;
PBMC-T cells : 15.25% ;
PBMC-Erythroblasts : 14.29% ;
Human metapneumovirus
PBMC-Macrophage : 79.10% ;
PBMC-Eosinophil cells : 60.00% ;
PBMC-Platelets : 48.25% ;
PBMC-T cells : 28.22% ;
PBMC-B cells : 20.78% ;
Echovirus E8
PBMC-Macrophage : 79.10% ;
PBMC-Eosinophil cells : 60.00% ;
PBMC-Platelets : 48.25% ;
PBMC-T cells : 28.22% ;
PBMC-B cells : 20.78% ;
PBMC-Platelets : 62.26% ;
PBMC-Macrophage : 20.90% ;
PBMC-Monocytes : 19.61% ;
PBMC-T cells : 15.25% ;
PBMC-Erythroblasts : 14.29% ;
Human rotavirus strain WA
PBMC-Macrophage : 79.10% ;
PBMC-Eosinophil cells : 60.00% ;
PBMC-Platelets : 48.25% ;
PBMC-T cells : 28.22% ;
PBMC-B cells : 20.78% ;
PBMC-Platelets : 62.26% ;
PBMC-Macrophage : 20.90% ;
PBMC-Monocytes : 19.61% ;
PBMC-T cells : 15.25% ;
PBMC-Erythroblasts : 14.29% ;
Mammalian orthoreovirus
PBMC-Macrophage : 79.10% ;
PBMC-Eosinophil cells : 60.00% ;
PBMC-Platelets : 48.25% ;
PBMC-T cells : 28.22% ;
PBMC-B cells : 20.78% ;
Human alphaherpesvirus 1
PBMC-Macrophage : 78.17% ;
PBMC-Eosinophil cells : 70.00% ;
PBMC-Platelets : 67.88% ;
PBMC-Monocytes : 27.94% ;
PBMC-B cells : 20.78% ;
Lung-Ciliated cells : 15.69% ;
Lung-Macrophages : 11.76% ;
Lung-Secretory cells : 6.98% ;
Lung-ATII : 6.67% ;
Lung-Secretory cells : 5.23% ;
Coxsackievirus B1
PBMC-Macrophage : 78.17% ;
PBMC-Eosinophil cells : 70.00% ;
PBMC-Platelets : 67.88% ;
PBMC-Monocytes : 27.94% ;
PBMC-B cells : 20.78% ;
Lung-Ciliated cells : 13.07% ;
PBMC-Macrophage : 10.45% ;
Lung-Secretory cells : 6.40% ;
PBMC-Monocytes : 5.39% ;
Lung-ATII : 6.67% ;
Lung-Secretory cells : 5.23% ;
Human mastadenovirus C
PBMC-Macrophage : 78.17% ;
PBMC-Eosinophil cells : 70.00% ;
PBMC-Platelets : 67.88% ;
PBMC-Monocytes : 27.94% ;
PBMC-B cells : 20.78% ;
PBMC-Macrophage : 19.78% ;
Lung-Ciliated cells : 13.07% ;
PBMC-Macrophage : 10.45% ;
Lung-Secretory cells : 6.40% ;
PBMC-Monocytes : 5.39% ;
Severe acute respiratory syndrome coronavirus 2
Lung-Smooth muscle cells : 68.79% ;
Lung-Fibroblasts : 68.39% ;
Lung-ATI : 68.28% ;
Lung-B cells : 56.52% ;
Lung-Endothelial cells : 54.71% ;
PBMC-Macrophage : 29.10% ;
Feline panleukopenia virus
PBMC-Erythroblasts : 66.56% ;
PBMC-Macrophage : 23.13% ;
PBMC-Eosinophil cells : 20.00% ;
Lung-Macrophages : 11.76% ;
PBMC-B cells : 11.69% ;
Guanarito mammarenavirus
PBMC-Erythroblasts : 66.56% ;
PBMC-Macrophage : 23.13% ;
PBMC-Eosinophil cells : 20.00% ;
Lung-Macrophages : 11.76% ;
PBMC-B cells : 11.69% ;
Argentinian mammarenavirus
PBMC-Erythroblasts : 66.56% ;
PBMC-Macrophage : 23.13% ;
PBMC-Eosinophil cells : 20.00% ;
Lung-Macrophages : 11.76% ;
PBMC-B cells : 11.69% ;
Machupo mammarenavirus
PBMC-Erythroblasts : 66.56% ;
PBMC-Macrophage : 23.13% ;
PBMC-Eosinophil cells : 20.00% ;
Lung-Macrophages : 11.76% ;
PBMC-B cells : 11.69% ;
Mouse mammary tumor virus
PBMC-Erythroblasts : 66.56% ;
PBMC-Macrophage : 23.13% ;
PBMC-Eosinophil cells : 20.00% ;
Lung-Macrophages : 11.76% ;
PBMC-B cells : 11.69% ;
Canine parvovirus
PBMC-Erythroblasts : 66.56% ;
PBMC-Macrophage : 23.13% ;
PBMC-Eosinophil cells : 20.00% ;
Lung-Macrophages : 11.76% ;
PBMC-B cells : 11.69% ;
Feline immunodeficiency virus
PBMC-T cells : 60.42% ;
PBMC-B cells : 50.65% ;
PBMC-Monocytes : 31.05% ;
PBMC-Macrophage : 29.66% ;
Lung-Endothelial cells : 24.33% ;
Human immunodeficiency virus 1
PBMC-T cells : 60.42% ;
PBMC-B cells : 50.65% ;
PBMC-Monocytes : 31.05% ;
PBMC-Macrophage : 29.66% ;
Lung-Endothelial cells : 24.33% ;
PBMC-T cells : 24.53% ;
PBMC-Eosinophil cells : 10.00% ;
Human immunodeficiency virus 2
PBMC-T cells : 60.42% ;
PBMC-B cells : 50.65% ;
PBMC-Monocytes : 31.05% ;
PBMC-Macrophage : 29.66% ;
Lung-Endothelial cells : 24.33% ;
PBMC-T cells : 24.53% ;
PBMC-Eosinophil cells : 10.00% ;
Bovine leukemia virus
PBMC-Macrophage : 59.14% ;
PBMC-B cells : 29.22% ;
PBMC-Eosinophil cells : 20.00% ;
PBMC-Platelets : 18.58% ;
PBMC-T cells : 16.75% ;
Chikungunya virus
PBMC-Macrophage : 46.64% ;
PBMC-B cells : 18.18% ;
Lung-Ciliated cells : 16.78% ;
PBMC-Erythroblasts : 11.62% ;
PBMC-T cells : 11.17% ;
Nipah henipavirus
Lung-Endothelial cells : 42.34% ;
Lung-Ciliated cells : 36.38% ;
Lung-Secretory cells : 27.33% ;
Lung-B cells : 26.09% ;
Lung-Smooth muscle cells : 24.83% ;
Hendra henipavirus
Lung-Endothelial cells : 42.34% ;
Lung-Ciliated cells : 36.38% ;
Lung-Secretory cells : 27.33% ;
Lung-B cells : 26.09% ;
Lung-Smooth muscle cells : 24.83% ;
Rhinovirus C
Lung-Ciliated cells : 37.47% ;
Lung-Secretory cells : 11.63% ;
Vesicular stomatitis virus
PBMC-Macrophage : 34.14% ;
Lung-Ciliated cells : 22.66% ;
Lung-Secretory cells : 11.63% ;
PBMC-B cells : 9.74% ;
Lung-Smooth muscle cells : 9.02% ;
Human mastadenovirus D
PBMC-Macrophage : 33.21% ;
PBMC-Eosinophil cells : 10.00% ;
PBMC-B cells : 7.14% ;
PBMC-T cells : 6.98% ;
PBMC-Monocytes : 6.05% ;
Lung-Ciliated cells : 13.07% ;
PBMC-Macrophage : 10.45% ;
Lung-Secretory cells : 6.40% ;
PBMC-Monocytes : 5.39% ;
Bovine viral diarrhea virus 1
PBMC-Macrophage : 33.21% ;
PBMC-Eosinophil cells : 10.00% ;
PBMC-B cells : 7.14% ;
PBMC-T cells : 6.98% ;
PBMC-Monocytes : 6.05% ;
Human mastadenovirus B
PBMC-Macrophage : 33.21% ;
PBMC-Eosinophil cells : 10.00% ;
PBMC-B cells : 7.14% ;
PBMC-T cells : 6.98% ;
PBMC-Monocytes : 6.05% ;
Human betaherpesvirus 6A
PBMC-Macrophage : 33.21% ;
PBMC-Eosinophil cells : 10.00% ;
PBMC-B cells : 7.14% ;
PBMC-T cells : 6.98% ;
PBMC-Monocytes : 6.05% ;
Human betaherpesvirus 6
PBMC-Macrophage : 33.21% ;
PBMC-Eosinophil cells : 10.00% ;
PBMC-B cells : 7.14% ;
PBMC-T cells : 6.98% ;
PBMC-Monocytes : 6.05% ;
Measles morbillivirus
PBMC-Macrophage : 33.21% ;
PBMC-Eosinophil cells : 10.00% ;
PBMC-B cells : 7.14% ;
PBMC-T cells : 6.98% ;
PBMC-Monocytes : 6.05% ;
Coxsackievirus A16
PBMC-Macrophage : 30.22% ;
Enterovirus A71
PBMC-Macrophage : 30.22% ;
JC polyomavirus
PBMC-Platelets : 28.73% ;
PBMC-Eosinophil cells : 20.00% ;
PBMC-Macrophage : 9.14% ;
PBMC-Monocytes : 8.66% ;
PBMC-T cells : 7.78% ;
Human papillomavirus type 16
PBMC-Platelets : 25.66% ;
PBMC-Eosinophil cells : 20.00% ;
PBMC-T cells : 9.07% ;
PBMC-Macrophage : 8.21% ;
PBMC-Monocytes : 7.03% ;
PBMC-Eosinophil cells : 10.00% ;
PBMC-Platelets : 7.31% ;
Xenotropic murine leukemia virus
PBMC-Macrophage : 24.81% ;
Lung-Ciliated cells : 16.99% ;
PBMC-B cells : 9.74% ;
PBMC-T cells : 8.57% ;
PBMC-Platelets : 7.50% ;
Polytropic murine leukemia virus
PBMC-Macrophage : 24.81% ;
Lung-Ciliated cells : 16.99% ;
PBMC-B cells : 9.74% ;
PBMC-T cells : 8.57% ;
PBMC-Platelets : 7.50% ;
Simian immunodeficiency virus
PBMC-T cells : 24.53% ;
PBMC-Eosinophil cells : 10.00% ;
Human betaherpesvirus 7
PBMC-T cells : 24.53% ;
PBMC-Eosinophil cells : 10.00% ;
Marburg marburgvirus
PBMC-Macrophage : 22.20% ;
PBMC-Macrophage : 17.54% ;
Lung-Ciliated cells : 6.97% ;
Lung-Macrophages : 5.88% ;
Ebola virus
PBMC-Macrophage : 22.20% ;
PBMC-Macrophage : 17.54% ;
Lung-Ciliated cells : 6.97% ;
Lung-Macrophages : 5.88% ;
Lung-Ciliated cells : 9.37% ;
Lung-Smooth muscle cells : 7.91% ;
Lung-Endothelial cells : 6.40% ;
Lung-Secretory cells : 5.81% ;
Lung-Fibroblasts : 5.45% ;
Human alphaherpesvirus 3
PBMC-Macrophage : 20.71% ;
PBMC-B cells : 11.69% ;
Lung-Ciliated cells : 10.68% ;
PBMC-Eosinophil cells : 10.00% ;
PBMC-T cells : 9.57% ;
Varicella Zoster Virus
PBMC-Macrophage : 20.71% ;
PBMC-B cells : 11.69% ;
Lung-Ciliated cells : 10.68% ;
PBMC-Eosinophil cells : 10.00% ;
PBMC-T cells : 9.57% ;
Lymphocytic choriomeningitis mammarenavirus
PBMC-Macrophage : 17.54% ;
Lung-Ciliated cells : 6.97% ;
Lung-Macrophages : 5.88% ;
Zika virus
PBMC-Macrophage : 17.54% ;
Lung-Ciliated cells : 6.97% ;
Lung-Macrophages : 5.88% ;
Middle East respiratory syndrome-related coronavirus
Lung-ATII : 13.33% ;
PBMC-Macrophage : 9.89% ;
Coxsackievirus B2
Lung-Ciliated cells : 13.07% ;
PBMC-Macrophage : 10.45% ;
Lung-Secretory cells : 6.40% ;
PBMC-Monocytes : 5.39% ;
Human mastadenovirus E
Lung-Ciliated cells : 13.07% ;
PBMC-Macrophage : 10.45% ;
Lung-Secretory cells : 6.40% ;
PBMC-Monocytes : 5.39% ;
Human mastadenovirus A
Lung-Ciliated cells : 13.07% ;
PBMC-Macrophage : 10.45% ;
Lung-Secretory cells : 6.40% ;
PBMC-Monocytes : 5.39% ;
Coxsackievirus B4
Lung-Ciliated cells : 13.07% ;
PBMC-Macrophage : 10.45% ;
Lung-Secretory cells : 6.40% ;
PBMC-Monocytes : 5.39% ;
Coxsackievirus B6
Lung-Ciliated cells : 13.07% ;
PBMC-Macrophage : 10.45% ;
Lung-Secretory cells : 6.40% ;
PBMC-Monocytes : 5.39% ;
Human mastadenovirus F
Lung-Ciliated cells : 13.07% ;
PBMC-Macrophage : 10.45% ;
Lung-Secretory cells : 6.40% ;
PBMC-Monocytes : 5.39% ;
Coxsackievirus B3
Lung-Ciliated cells : 13.07% ;
PBMC-Macrophage : 10.45% ;
Lung-Secretory cells : 6.40% ;
PBMC-Monocytes : 5.39% ;
Coxsackievirus B5
Lung-Ciliated cells : 13.07% ;
PBMC-Macrophage : 10.45% ;
Lung-Secretory cells : 6.40% ;
PBMC-Monocytes : 5.39% ;
Respiratory syncytial virus
PBMC-Macrophage : 10.45% ;
Porcine reproductive and respiratory syndrome virus
PBMC-Eosinophil cells : 10.00% ;
PBMC-Platelets : 7.31% ;
Sin Nombre orthohantavirus
Lung-Endothelial cells : 8.67% ;
Lung-Smooth muscle cells : 6.38% ;
Andes orthohantavirus
Lung-Endothelial cells : 8.67% ;
Lung-Smooth muscle cells : 6.38% ;
Ecotropic murine leukemia virus
Lung-Ciliated cells : 8.28% ;
Rabies lyssavirus
Lung-Ciliated cells : 6.32% ;
Lung-Smooth muscle cells : 5.83% ;

Contact Us

E-mail: chendongsheng@genomics.cn

Address: Build 11, Beishan Industrial Zone, Yantian District, Shenzhen, 518083, China

Copyright © VThunter 2020-2021 ShenZhen, Guangdong province, China